期刊论文详细信息
Pharmaceuticals
Development and Successful Validation of Simple and Fast TLC Spot Tests for Determination of Kryptofix® 2.2.2 and Tetrabutylammonium in 18F-Labeled Radiopharmaceuticals
Matthias Kuntzsch1  Gerald Reischl1  Gabriele J. Kienzle1  Nils Brüggener1  Denis Lamparter1  Marco Müller2 
[1] Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tübingen, Röntgenweg 15, Tübingen D-72076, Germany;Department of Radiochemistry, ABX GmbH, Heinrich-Gläser-Straße 10, Radeberg D-01454, Germany;
关键词: Kryptofix® 2.2.2;    tetrabutylammonium;    fluorine-18;    quality control;    thin layer chromatography (TLC) spot test;   
DOI  :  10.3390/ph7050621
来源: DOAJ
【 摘 要 】

Kryptofix® 2.2.2 (Kry) or tetrabutylammonium (TBA) are commonly usedas phase transfer catalysts in 18F-radiopharmaceutical productions for positron emission tomography (PET). Due to their toxicity, quality control has to be performed before administration of the tracer to assure that limit concentration of residual reagent is not reached. Here, we describe the successful development and pharmaceutical validation(for specificity, accuracy and detection limit) of a simplified color spot test on TLC plates. We were able to prove its applicability as a general, time and resources saving, easy to handle and reliable method in daily routine analyzing 18F-tracer formulations for Kry(in [18F]FDG or [18F]FECh) or TBA contaminations (in [18F]FLT) with special regard to complex matrix compositions.

【 授权许可】

Unknown   

  文献评价指标  
  下载次数:0次 浏览次数:0次